Optiscan Imaging Ltd

NEW
ASX:OIL (Australia)  
A$ 0.14 (0%) Aug 3
At Loss
P/B:
6.90
Market Cap:
A$ 151.41M ($ 105.98M)
Enterprise V:
A$ 135.19M ($ 94.63M)
Volume:
252.42K
Avg Vol (2M):
278.50K
Trade In:
Volume:
252.42K
At Loss
Avg Vol (2M):
278.50K

Business Description

Description
Optiscan Imaging Ltd is engaged in the development, manufacture, and commercialization of endomicroscopic digital imaging technology solutions for medical, translational, and pre-clinical applications. Its technology offers real-time, 3D, in vivo imaging at the single-cell level, in a non-destructive manner that enables clinicians to make immediate informed decisions. Its products include InVivage, ViewnVivo, and Customisation. Its geographical segments include Australia, Germany, Norway, China, and the United States.
Name Current Vs Industry Vs History
Cash-To-Debt
11.81
Equity-to-Asset
0.88
Debt-to-Equity
0.07
Debt-to-EBITDA
-0.22
Piotroski F-Score
2/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score
23.44
Distress
Grey
Safe
Beneish M-Score
-3.92
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI
29.61
9-Day RSI
42.82
14-Day RSI
49.34
3-1 Month Momentum %
22.73
6-1 Month Momentum %
50
12-1 Month Momentum %
35.93

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio
14.01
Quick Ratio
12.92
Cash Ratio
10.71
Days Inventory
1592.97
Days Sales Outstanding
1128.34
Days Payable
561.04

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio
-9.7
Shareholder Yield %
-11.36
Name Current Vs Industry Vs History
Gross Margin %
41.32
Operating Margin %
-1341.75
Net Margin %
-1052.08
EBITDA Margin %
-999.28
FCF Margin %
-979.77
OCF Margin %
-943.9
ROE %
-53.24
ROA %
-45.37
ROIC %
-168.83
3-Year ROIIC %
-179.54
ROC (Joel Greenblatt) %
-166.61
ROCE %
-49.56

GF Value Rank

Name Current Vs Industry Vs History
PS Ratio
145
PB Ratio
6.9
Price-to-Tangible-Book
7.25
EV-to-EBIT
-18.62
EV-to-EBITDA
-19.41
EV-to-Revenue
193.97
EV-to-FCF
-22.09
Price-to-GF-Value
3.63
Price-to-Net-Current-Asset-Value 7.25
Price-to-Net-Cash 14.5
Earnings Yield (Greenblatt) %
-5.37
FCF Yield %
-4.51

Optiscan Imaging Ltd Filings

Filing Date Document Date Form
No Filing Data

Optiscan Imaging Ltd Stock Events

Financials Calendars
Event Date Price (A$)
No Event Data

Press Release

Subject Date
Optiscan Signs Know-How Agreement with Mayo Clinic 2024-05-13
10/Page

Articles on Optiscan Imaging Ltd

No articles.